ATUM Deep-Tech Commercial Founder (BioTech and Diagnostics) - Singapore at ATUM Ventures

Singapore, , Singapore -

Full Time

Start Date

Immediate

Expiry Date

23 Mar, 26

Salary

0.0

Posted On

23 Dec, 25

Experience

5 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Entrepreneurial Drive, Leadership Experience, Technology Commercialization, Process Development, Prototyping, Customer Engagement, Market Validation, Go-To-Market Strategy, Partnership Development, Financial Operations, Growth Infrastructure, Communication Skills, Team Building, Experimentation, Iteration, Problem Solving

Industry

Venture Capital and Private Equity Principals

Description

Why We Exist: ATUM exists to support courageous founders who turn differentiating tech into world-changing companies that solve critical challenges in Energy, Medtech and Advanced Manufacturing. We bring capital, operational muscle and partners from academia, industry, VC, and government who co-invest in every build. ATUM builds ventures from scratch by helping researchers, corporates and founders turn breakthrough research into venture-scale companies, backing them with capital, corporate networks, and the operational guidance to navigate everything from technical validation and grants to go-to-market and growth. We built and invested in 15 deep-tech ventures so far and have a portfolio of fast-growing ventures that are scaling globally. The Opportunity: Our Deep Tech Venture Building Programme leads the end‑to‑end creation of new startups from breakthrough technologies. We identify research‑backed innovations, validate them with our scientific council, assemble complementary founder teams and support these teams towards investment readiness and launch. About the Venture Aproxy is building a next-generation diagnostics platform to solve one of healthcare’s biggest bottlenecks: most clinical decisions depend on proteins, yet protein tests are slow, complex, and insensitive. Around 70% of medical decisions rely on lab tests, but key disease biomarkers exist at extremely low concentrations and cannot be amplified like DNA. As a result, samples are sent to central labs, results take days, and diagnosis and treatment are delayed, sometimes costing tens or hundreds of thousands of dollars per patient in avoidable medical and productivity losses. This problem is even more acute in veterinary medicine, where small sample volumes, fast disease progression, and weak follow-up make delays especially costly. Aproxy’s patented technology converts protein signals into DNA signals, unlocking 100–1,000× higher sensitivity than standard immunoassays in a one-pot, 20–30 minute workflow, with no wash steps and no new hardware. It delivers reference-lab–level sensitivity at point-of-care speed, enabling earlier detection, same-visit decisions, and entirely new tests that were previously impractical or impossible. The platform is chemistry-first, instrument-agnostic, and protected by multiple patent families covering the core protein-to-DNA mechanism and noise-suppression designs. We are looking for a future ATUM Commercial Founder to take this next wave of high-impact technologies out into the world. As a Commercial Founder, you'll lead the business and GTM strategy and execution from day one. You’ll pair with the Technical Founder to build a high-impact business, and set the foundations for scale & impact. This is not a “job.” It’s a founding journey. You’ll share in the risk, the upside, and the impact. How You'll Have Impact: You will be responsible for shaping the go-to-market and commercial strategy of a new deep-tech startup. You will work alongside the founder and inventor, who leads the scientific development, to identify a viable market application, build customer traction and secure funding to take your venture forward for scale. Translate complex technology into commercial opportunity. Identify high-value use cases, customer pain points and defensible market positions that turn technical advantage into economic leverage. Define and test the venture thesis. Partner with product and technical leads to validate assumptions further, continually refine positioning and stress-test business models under real-world market conditions. Drive early traction and partnerships. Engage with enterprise customers, strategic partners and ecosystem players to pilot, co-develop and secure initial commercial validation. Shape go-to-market strategy and scale pathways. Design routes to entry, pricing, sales motion, and partnerships for sustainable growth, balancing experimentation with operational discipline. Build the commercial foundation. Establish the early finance, operations, and growth infrastructure that enables speed without compromising rigor. Represent the venture externally. Be the face of the business to investors, partners, and early customers, communicating a clear narrative that connects deep technology with transformative impact. Who You Are: Proven entrepreneurial drive - you’ve started something complex from scratch and seen it through (start up, business line, product, etc.). You have leadership experience in pharmaceuticals, biotech, or healthcare, ideally with exposure to process development or technology commercialization. Ideally you'll have gained exposure through startups, research commercialisation or product engineering previously, with experience developing prototypes, models or novel IP. A strong builder mindset – you’re motivated by experimentation, iteration, and creating from scratch. High comfort in navigating ambiguity with a strong bias for action. Ability to be the connective tissue between complex technology and the business, constantly keeping the customer front of mind and communicating effectively. A talent magnet - you know what great looks like in terms of people, are excited to build a firepower team to deliver on your venture goals. What We Offer: A committed long-term deep-tech partner Partner with ATUM, Southeast Asia’s leading deep-tech venture builder, combining committed capital from Pre-Seed to Series A with a proven track record of building and backing 16+ top-percentile performing ventures. Direct access to enterprise demand and execution resources You will operate within ATUM’s Collective of corporate partners, early customers, labs, and domain experts. These relationships provide immediate opportunities to pilot, co-develop, and deploy technologies in real-world settings to accelerate validation, early traction, and the path to revenue. A structured path to de-risk deep-tech from day one ATUM provides a deliberate, milestone-driven venture creation structure that systematically de-risks technology, market, and execution so you’re not guessing what to build, when to raise, or how to bridge the gap between lab and market. A true co-founder role in building a category-defining deep-tech business You’ll have a seat as a co-founder with real ownership, real decisions, and the chance to take on the challenge to shape a category-defining deep-tech company from day one. ATUM is an equal opportunity employer and partner, whether you are exploring joining our team, our Venture Build Programme, or one of our Portfolio Companies. We welcome applicants of all backgrounds and identities, and our selection decisions are guided by our core values. If our mission resonates with you, we encourage you to apply.

Responsibilities

You will shape the go-to-market and commercial strategy of a new deep-tech startup, working alongside the founder to identify viable market applications and secure funding. Your role includes translating complex technology into commercial opportunities and driving early traction and partnerships.